Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5895|5|4|303-311

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.5, Iss.4, 2005-08, pp. : 303-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclooxygenase-2: a therapeutic target in angiogenesis

By Iniguez M.A.   Rodrguez A.   Volpert O.V.   Fresno M.   Redondo J.M.  

Trends in Molecular Medicine, Vol. 9, Iss. 2, 2003-02 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 527-532

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein E: Possible Therapeutic Target for Atherosclerosis

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 1, Iss. 2, 2001-12 ,pp. : 93-106

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinases: A Potential Therapeutic Target in Atherosclerosis

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 541-548

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of cyclooxygenase-2: a new targeted therapy for B-cell lymphoma?

By Phipps R.P.   Ryan E.   Bernstein S.H.  

Leukemia Research, Vol. 28, Iss. 2, 2004-02 ,pp. : 109-111

Elsevier

Access to resources Recommend Favorite